Pupillary Pathways

Triggerfish: Smart Contact Lens for Glaucoma Monitoring

Posted by Amanda Dexter on Apr 11, 2016 9:00:00 AM

Last month, the FDA (US Food and Drug Administration) granted a marketing license to a Swiss-based company called Sensimed for its smart contact lens that aims to tackle current limitations in monitoring intraocular pressure (IOP) in patients with glaucoma.

This sensor device is currently being utilized throughout Europe and has been studied in the US, but will hopefully start to be more widely available to practitioners and patients shortly for glaucoma monitoring.

Read More

Topics: Glaucoma

Topical Glaucoma Medications (Alpha-2 Agonists, CAIs, Miotics & Combo)

Posted by Amanda Dexter on Mar 3, 2016 9:00:00 AM

On Monday we reviewed the most important concepts associated with prostaglandin analogs and beta-blockers.

Today we will continue on with reviewing the mechanisms of action, dosages, side effects, contraindications, and preparations of topical alpha-2 agonists, carbonic anhydrase inhibitors, miotics, and combination medications. 

Read More

Topics: Glaucoma

Review of Topical Glaucoma Medications

Posted by Amanda Dexter on Feb 29, 2016 3:13:50 PM

Last week I attended a continuing education course in which we reviewed several difficult glaucoma patient cases. These were all patients with moderate to advanced glaucoma who showed progression and the subsequent need for adjustment of their current glaucoma treatment plans.

Additionally, most of these patients also presented with complicated medical histories, had allergies to certain classes of medications, responded poorly or ineffectively to prior topical glaucoma treatments, and had difficulties with compliance when multiple medications were needed. 

Read More

Topics: Glaucoma